[1]
|
Ellis, J., Oyston, P.C.F., Green, M. and Titball, R.W. (2002) Tularemia. Clinical Microbiology Reviews, 15, 631-646. https://doi.org/10.1128/CMR.15.4.631-646.2002
|
[2]
|
Tarnvik, A. (1989) Nature of Protective Immunity to Francisella tularensis. Reviews of Infectious Diseases, 11, 440-451. https://doi.org/10.1093/clinids/11.3.440
|
[3]
|
Bennett, J.E., Dolin, R. and Blaser, M.J. (2019) Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. E-Book, Elsevier Health Sciences, Amsterdam.
|
[4]
|
McCoy, G.W. and Chapin, C.W. (1912) Further Observations on a Plague-Like Disease of Rodents with a Preliminary Note on the Causative Agent, Bacterium tularense. Journal of Infectious Diseases, 10, 61-72. https://doi.org/10.1093/infdis/10.1.61
|
[5]
|
McCoy, G.W. and Chapin, C.W. (1912) Bacterium tularense, the Cause of a Plague-Like Disease of Rodents. Public Health Bulletin, 53, 17-23.
|
[6]
|
Hansen, C.M., Vogler, A.J., Keim, P., Wagner, D.M. and Hueffer, K. (2011) Tularemia in Alaska, 1938-2010. Acta Veterinaria Scandinavica, 53, 61. https://doi.org/10.1186/1751-0147-53-61
|
[7]
|
Oyston, P.C. (2008) Francisella tularensis: Unravelling the Secrets of an Intracellular Pathogen. Journal of Medical Microbiology, 57, 921-930. https://doi.org/10.1099/jmm.0.2008/000653-0
|
[8]
|
Wherry, W.B. and Lamb, B.H. (2004) Infection of Man with Bacterium tularense. The Journal of Infectious Diseases, 189, 1321-1329. https://doi.org/10.1093/infdis/189.7.1321
|
[9]
|
Francis, E. (1922) Cultivation of Bacterium tularense on Three Additional Mediums New to This Organism. Public Health Reports, 37, 987-989. https://doi.org/10.2307/4576373
|
[10]
|
Francis, E. and Evans, A.C. (1926) Agglutination, Cross-Agglutination, and Agglutinin Absorption in Tularaemia. Public Health Reports, 41, 1273-1295. https://doi.org/10.2307/4577917
|
[11]
|
Gc, L.E.F. (1922) Six Cases of Tularemia Occurring in Laboratory Workers. Public Health Reports, 37, 392-413. https://doi.org/10.2307/4576294
|
[12]
|
Sw, R. (1983) Tularemia: What’s in a Name? ASM News, 49, 63-65.
|
[13]
|
Ohara, S.O. (1954) Studies on Yato-Byo (Ohara’s Disease, Tularemia in Japan), Report I. The Japanese Journal of Experimental Medicine, 24, 69-79.
|
[14]
|
康成贵, 王正夫, 韩文奎. 我国首次人间土拉伦菌病流行病学调查报告(摘要)[J]. 医学研究通讯, 1980(10): 11-12.
|
[15]
|
郭从厚, 曾庆国, 王舜臣, 等. 西藏地区土拉弗菌病初步调查[J]. 中华流行病学杂志, 1981, 2(3): 176-181.
|
[16]
|
孔昭敏, 陈国仕, 金根源, 等. 新疆蜱媒自然疫源性疾病的调查研究[J]. 疾病预防控制通报, 1987, 2(3): 1-4.
|
[17]
|
蓬增昌, 耿玉利, 肖永康, 等. 山东半岛首次土拉弗菌病爆发流行调查报告[J]. 中华流行病学杂志, 1987, 8(5): 261-263.
|
[18]
|
张芳, 刘玮, 何君, 等. 我国北方部分地区土拉弗菌感染宿主动物的分子流行病学研究[J]. 军事医学科学院院刊, 2006, 30(2): 131-134.
|
[19]
|
Cowley, S.C. and Elkins, K.L. (2011) Immunity to Francisella. Frontiers in Microbiology, 2, 26. https://doi.org/10.3389/fmicb.2011.00026
|
[20]
|
de Carvalho, I.L., Ms, N. and de Morais, J.D. (2009) Tularémia. Acta Médica Portuguesa, 3, 281-290.
|
[21]
|
Foley, J.E. and Nieto, N.C. (2010) Tularemia. Veterinary Microbiology, 140, 332-338. https://doi.org/10.1016/j.vetmic.2009.07.017
|
[22]
|
Collier, L., Balows, A., and Sussman, M. (1998) Topley and Wilson’s Microbiology and Microbial Infections. John Wiley & Sons, New York, 1347-1349.
|
[23]
|
Petersen, J.M., Mead, P.S. and Schriefer, M.E. (2009) Francisella tularensis: An Arthropod-Borne Pathogen. Veterinary Research, 40, 7.
|
[24]
|
Jantzen, E., Berdal, B.P. and Omland, T. (1979) Cellular Fatty Acid Composition of Francisella tularensis. Journal of Clinical Microbiology, 10, 928-930.
|
[25]
|
陈为民. 人兽共患病[M]. 武汉: 湖北科学技术出版社, 2006: 634.
|
[26]
|
Beckstrom-Sternberg, S.M., Auerbach, R.K., Godbole, S., et al. (2007) Complete Genomic Characterization of a Pathogenic A.II Strain of Francisella tularensis Subspecies tularensis. PLoS ONE, 2, e947. https://doi.org/10.1371/journal.pone.0000947
|
[27]
|
Keim, P., Johansson, A. and Wagner, D.M. (2007) Molecular Epidemiology, Evolution, and Ecology of Francisella. Annals of the New York Academy of Sciences, 1105, 30-66. https://doi.org/10.1196/annals.1409.011
|
[28]
|
Celli, J. and Zahrt, T.C. (2013) Mechanisms of Francisella tularensis Intracellular Pathogenesis. Cold Spring Harbor Perspectives in Medicine, 3, a10314. https://doi.org/10.1101/cshperspect.a010314
|
[29]
|
Maurin, M. and Gyuranecz, M. (2016) Tularaemia: Clinical Aspects in Europe. The Lancet Infectious Diseases, 16, 113-124. https://doi.org/10.1016/S1473-3099(15)00355-2
|
[30]
|
Evans, M.E. (1985) Francisella tularensis. Infection Control, 6, 381-383.
|
[31]
|
Gill, V. and Cunha, B.A. (1997) Tularemia Pneumonia. Seminars in Respiratory Infections, 12, 61-67.
|
[32]
|
Dennis, D.T., Inglesby, T.V., Henderson, D.A., et al. (2001) Tularemia as a Biological Weapon: Medical and Public Health Management. The Journal of the American Medical Association, 285, 2763-2773. https://doi.org/10.1001/jama.285.21.2763
|
[33]
|
Rossow, H., Sissonen, S., Koskela, K.A., et al. (2014) Detection of Francisella tularensis in Voles in Finland. Vector-Borne and Zoonotic Diseases, 14, 193-198. https://doi.org/10.1089/vbz.2012.1255
|
[34]
|
Luque-Larena, J.J., Mougeot, F., Arroyo, B., et al. (2017) Irruptive Mammal Host Populations Shape Tularemia Epidemiology. PLOS Pathogens, 13, e1006622. https://doi.org/10.1371/journal.ppat.1006622
|
[35]
|
Forminska, K., Zasada, A.A., Rastawicki, W., et al. (2015) Increasing Role of Arthropod Bites in Tularaemia Transmission in Poland-Case Reports and Diagnostic Methods. Annals of Agricultural and Environmental Medicine, 22, 443-446. https://doi.org/10.5604/12321966.1167711
|
[36]
|
Roberts, R.R., Hota, B., Ahmad, I., et al. (2009) Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship. Clinical Infectious Diseases, 49, 1175-1184. https://doi.org/10.1086/605630
|
[37]
|
Pierini, L.M. (2006) Uptake of Serum-Opsonized Francisella tularensis by Macrophages Can Be Mediated by Class A Scavenger Receptors. Cellular Microbiology, 8, 1361-1370. https://doi.org/10.1111/j.1462-5822.2006.00719.x
|
[38]
|
Chong, A. and Celli, J. (2010) The Francisella Intracellular Life Cycle: Toward Molecular Mechanisms of Intracellular Survival and Proliferation. Frontiers in Microbiology, 1, 138. https://doi.org/10.3389/fmicb.2010.00138
|
[39]
|
Broms, J.E., Meyer, L. and Sjostedt, A. (2017) A Mutagenesis-Based Approach Identifies Amino Acids in the N-terminal part of Francisella tularensis IglE that Critically Control Type VI System-Mediated Secretion. Virulence, 8, 821-847. https://doi.org/10.1080/21505594.2016.1258507
|
[40]
|
Brock, S.R. and Parmely, M.J. (2017) Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain Schu S4. Infection and Immunity, 85, 1-15. https://doi.org/10.1128/IAI.00424-17
|
[41]
|
Ramos, M.M., Palfreeman, M., Setzu, N., et al. (2018) Obesity Exacerbates the Cytokine Storm Elicited by Francisella tularensis Infection of Females and Is Associated with Increased Mortality. BioMed Research International, 2018, Article ID: 3412732. https://doi.org/10.1155/2018/3412732
|
[42]
|
Kopping, E.J., Doyle, C.R., Sampath, V. and Thanassi, D.G. (2019) Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence. Infection and Immunity, 87. https://doi.org/10.1128/IAI.00823-18
|
[43]
|
Grunow, R., Splettstoesser, W., Mcdonald, S., et al. (2000) Detection of Francisella tularensis in Biological Specimens Using a Capture Enzyme-Linked Immunosorbent Assay, an Immunochromatographic Handheld Assay, and a PCR. Clinical and Diagnostic Laboratory Immunology, 7, 86-90. https://doi.org/10.1128/CDLI.7.1.86-90.2000
|
[44]
|
Petersen, J.M., Schriefer, M.E., Gage, K.L., Montenieri, J.A., Carter, L.G., Stanley, M. and Chu, M.C. (2004) Methods for Enhanced Culture Recovery of Francisella tularensis. Applied and Environmental Microbiology, 70, 3733-3735. https://doi.org/10.1128/AEM.70.6.3733-3735.2004
|
[45]
|
Zeidner, N.S., Carter, L.G., Monteneiri, J.A., et al. (2004) An Outbreak of Francisella tularensis in Captive Prairie Dogs: An Immunohistochemical Analysis. Journal of Veterinary Diagnostic Investigation, 16, 150-152. https://doi.org/10.1177/104063870401600210
|
[46]
|
Aronova, N.V. and Pavlovich, N.V. (2000) The Use if Francisella tularensis Lipopolysaccharide in the Dot Solid Phase Enzyme Immunoassay. Zhurnalmikrobiologii, epidemiologii, iimmunobiologii, 5, 75-78.
|
[47]
|
Berdal, B.P., Mehl, R., Haaheim, H., et al. (2000) Field Detection of Francisella tularensis. Scandinavian Journal of Infectious Diseases, 32, 287-291. https://doi.org/10.1080/00365540050165938
|
[48]
|
Zhao, J., Yang, R., Lu, J., et al. (1996) Detection of Francisella tularensis by the Polymerase Chain Reaction. Journal of Medical Microbiology, 45, 477-482. https://doi.org/10.1099/00222615-45-6-477
|
[49]
|
Porsch-Ozcurumez, M., Kischel, N., Priebe, H., et al. (2004) Comparison of Enzyme-Linked Immunosorbent Assay, Western Blotting, Microagglutination, Indirect Immunofluorescence Assay, and Flow Cytometry for Serological Diagnosis of Tularemia. Clinical and Diagnostic Laboratory Immunology, 11, 1008-1015. https://doi.org/10.1128/CDLI.11.6.1008-1015.2004
|
[50]
|
李志清, 刘增加, 上官改珍, 等. 巢式-PCR检测蜱体中土拉弗氏菌的fopA基因及血清学调查[J]. 寄生虫与医学昆虫学报, 2014, 21(3): 160-164.
|
[51]
|
Johansson, A., Ibrahim, A., Goransson, I., et al. (2000) Evaluation of PCR-Based Methods for Discrimination of Francisella Species and Subspecies and Development of a Specific PCR that Distinguishes the Two Major Subspecies of Francisella tularensis. Journal of Clinical Microbiology, 38, 4180-4185.
|
[52]
|
Barns, S.M., Grow, C.C., Okinaka, R.T., Keim, P. and Kuske, C.R. (2005) Detection of Diverse New Francisella-Like Bacteria in Environmental Samples. Applied and Environmental Microbiology, 71, 5494-5500. https://doi.org/10.1128/AEM.71.9.5494-5500.2005
|
[53]
|
Sjostedt, A., Eriksson, U., Berglund, L. and T?rnvik, A. (1997) Detection of Francisella tularensis in Ulcers of Patients with Tularemia by PCR. Journal of Clinical Microbiology, 35, 1045-1048.
|
[54]
|
Sreter-Lancz, Z., Szell, Z., Sreter, T. and Márialigeti, K. (2009) Detection of a Novel Francisella in Dermacentor reticulatus: A Need for Careful Evaluation of PCR-Based Identification of Francisella tularensis in Eurasian Ticks. Vector-Borne and Zoonotic Diseases, 9, 123-126. https://doi.org/10.1089/vbz.2008.0010
|
[55]
|
Tomaso, H., Scholz, H.C., Neubauer, H., et al. (2007) Real-Time PCR Using Hybridization Probes for the Rapid and Specific Identification of Francisella tularensis Subspecies Tularensis. Molecular and Cellular Probes, 21, 12-16. https://doi.org/10.1016/j.mcp.2006.06.001
|
[56]
|
宫英, 强新, 李金海, 等. 土拉菌套式PCR检测技术的研究[J]. 现代预防医学, 2007, 34(23): 4576-4577.
|
[57]
|
张敏丽, 郭兆彪, 汪晓辉, 等. 土拉弗朗西斯氏菌PCR-EIA检测技术的研究[J]. 解放军预防医学杂志, 1999(4): 264-266.
|
[58]
|
Fulop, M., Leslie, D. and Titball, R. (1996) A Rapid, Highly Sensitive Method for the Detection of Francisella tularensis in Clinical Samples Using the Polymerase Chain Reaction. The American Journal of Tropical Medicine and Hygiene, 54, 364-366. https://doi.org/10.4269/ajtmh.1996.54.364
|
[59]
|
Sellek, R., Jimenez, O., Aizpurua, C., et al. (2008) Recovery of Francisella tularensis from Soil Samples by Filtration and Detection by Real-Time PCR and cELISA. Journal of Environmental Monitoring, 10, 362-369. https://doi.org/10.1039/b716608g
|
[60]
|
Rastawicki, W., Forminska, K., Zasada, A.A. (2018) Development and Evaluation of a Latex Agglutination Test for the Identification of Francisella tularensis Subspecies Pathogenic for Human. Polish Journal of Microbiology, 67, 241-244. https://doi.org/10.21307/pjm-2018-030
|
[61]
|
史清海. 土拉弗朗西斯氏菌、炭疽芽孢杆菌定量PCR检测技术的研究[D]: [硕士学位论文]. 北京: 中国人民解放军军事医学科学院, 2010.
|
[62]
|
张芳. 我国土拉弗氏菌分子流行病学调查研究[D]: [博士学位论文]. 北京: 中国人民解放军军事医学科学院, 2008.
|
[63]
|
Sarva, S.T., Waldo, R.H., Belland, R.J. and Klose, K.E. (2016) Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida. PLoS ONE, 11, e158631. https://doi.org/10.1371/journal.pone.0158631
|
[64]
|
WHO (2007) WHO Guidelines on Tularemia. Geneva, Switzerland.
|
[65]
|
Eliasson, H., Broman, T., Forsman, M. and B?ck, E. (2006) Tularemia: Current Epidemiology and Disease Management. Infectious Disease Clinics of North America, 20, 289-311. https://doi.org/10.1016/j.idc.2006.03.002
|
[66]
|
Maurin, M., Pelloux, I., Brion, J.P., Del Ban?, J.-N. and Picard, A. (2011) Human Tularemia in France, 2006-2010. Clinical Infectious Diseases, 53, e133-e141. https://doi.org/10.1093/cid/cir612
|
[67]
|
Thomas, L.D. and Schaffner, W. (2010) Tularemia Pneumonia. Infectious Disease Clinics of North America, 24, 43-55. https://doi.org/10.1016/j.idc.2009.10.012
|
[68]
|
Karagoz, S., Kilic, S., Berk, E., et al. (2013) Francisella tularensis Bacteremia: Report of Two Cases and Review of the Literature. New Microbiologica, 36, 315-323.
|
[69]
|
Caspar, Y., Hennebique, A. and Maurin, M. (2018) Antibiotic Susceptibility of Francisella tularensis Subsp. Holarctica Strains Isolated from Tularaemia Patients in France between 2006 and 2016. Journal of Antimicrobial Chemotherapy, 73, 687-691. https://doi.org/10.1093/jac/dkx460
|
[70]
|
Perez-Castrillon, J.L., Bachiller-Luque, P., Martin-Luquero, M., Mena-Martín, F.J. and Herreros, V. (2001) Tularemia Epidemic in Northwestern Spain: Clinical Description and Therapeutic Response. Clinical Infectious Diseases, 33, 573-576. https://doi.org/10.1086/322601
|
[71]
|
Hansen, B., Tilseth, R., Finjord, T. and Bruserud, ?. (2018) Francisella tularensis Bacteraemia Causing Multi-Organ Failure. Oxford Medical Case Reports, 2018, omy067. https://doi.org/10.1093/omcr/omy067
|
[72]
|
Hamblin, K.A., Flick-Smith, H., Barnes, K.B., et al. (2019) Disulfiram, an Alcohol Dependence Therapy, Can Inhibit the in vitro growth of Francisella tularensis. International Journal of Antimicrobial Agents, 54, 85-88. https://doi.org/10.1016/j.ijantimicag.2019.04.002
|
[73]
|
Bossi, P. and Bricaire, F. (2003) Tularemia, a Potential Bioterrorism Weapon. La Presse Médicale, 32, 1126-1130.
|
[74]
|
Katz, L., Orr-Urteger, A., Brenner, B. and Hourvitz, A. (2002) Tularemia as a Biological Weapon. Harefuah, 141, 78-83+120.
|
[75]
|
Mierzynska, D. and Hermanowska-Szpakowicz, T. (2002) Tularemia as a Potential Weapon of Bioterrorists. Medycynapracy, 53, 279-281.
|
[76]
|
Foshay, L. (1932) Prophylactic Vaccination against Tularemia. American Journal of Clinical Pathology, 2, 7-10. https://doi.org/10.1093/ajcp/2.1.7
|
[77]
|
Saslaw, S., Eigelsbach, H.T., Prior, J.A., et al. (1961) Tularemia Vaccine Study. II. Respiratory Challenge. Archives of Internal Medicine, 107, 702-714. https://doi.org/10.1001/archinte.1961.03620050068007
|
[78]
|
Saslaw, S., Eigelsbach, H.T., Wilson, H.E., et al. (1961) Tularemia Vaccine Study. I. Intracutaneous Challenge. Archives of Internal Medicine, 107, 689-701.
|
[79]
|
R P. (1967) History and Incidence of Tularemia in Soviet Union: A Review. The Institute of Contemporary Russian Studies, Fordham University, Bronx, New York.
|
[80]
|
Tigertt, W.D. (1962) Soviet Viable Pasteurella Tularensis Vaccines. A Review of Selected Articles. Bacteriological Reviews, 26, 354-373.
|
[81]
|
Eigelsbach, H.T. and Downs, C.M. (1961) Prophylactic Effectiveness of Live and Killed Tularemia Vaccines. I. Production of Vaccine and Evaluation in the White Mouse and Guinea Pig. The Journal of Immunology, 87, 415-425.
|
[82]
|
Mccrumb, F.R. (1961) Aerosol Infection of Man with Pasteurella Tularensis. Bacteriological Reviews, 25, 262-267.
|
[83]
|
Hornick, R.B. and Eigelsbach, H.T. (1966) Aerogenic Immunization of Man with Live Tularemia Vaccine. Bacteriological Reviews, 30, 532-538.
|
[84]
|
Burke, D.S. (1977) Immunization against Tularemia: Analysis of the Effectiveness of Live Francisella tularensis Vaccine in Prevention of Laboratory-Acquired Tularemia. The Journal of Infectious Diseases, 135, 55-60. https://doi.org/10.1093/infdis/135.1.55
|
[85]
|
Hartley, G., Taylor, R., Prior, J., et al. (2006) Grey Variants of the Live Vaccine Strain of Francisella tularensis Lack Lipopolysaccharide O-Antigen, Show Reduced Ability to Survive in Macrophages and Do Not Induce Protective Immunity in Mice. Vaccine, 24, 989-996. https://doi.org/10.1016/j.vaccine.2005.08.075
|
[86]
|
Sunagar, R., Kumar, S., Franz, B.J. and Gosselin, E. (2016) Tularemia Vaccine Development: Paralysis or Progress? Vaccine, 6, 9-23. https://doi.org/10.2147/VDT.S85545
|
[87]
|
Marohn, M.E. and Barry, E.M. (2013) Live Attenuated Tularemia Vaccines: Recent Developments and Future Goals. Vaccine, 31, 3485-3491. https://doi.org/10.1016/j.vaccine.2013.05.096
|
[88]
|
Tian, D., Uda, A., Park, E.S., et al. (2018) Evaluation of Francisella tularensis ΔpdpC as a Candidate Live Attenuated Vaccine against Respiratory Challenge by a Virulent SCHU P9 Strain of Francisella tularensis in a C57BL/6J Mouse Model. Microbiology and Immunology, 62, 24-33. https://doi.org/10.1111/1348-0421.12555
|
[89]
|
Stefanetti, G., Okan, N., Fink, A., Gardner, E. and Kasper, D.L. (2019) Glycoconjugate Vaccine Using a Genetically Modified O Antigen Induces Protective Antibodies to Francisella tularensis. Proceedings of the National Academy of Sciences of the United States of America, 116, 7062-7070. https://doi.org/10.1073/pnas.1900144116
|